GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93020C00040AURO VACCINES LLC

Overview

Award facts

Net obligations
$10.71M
$10,706,003of $26.40M potential value
Outlays (paid to date)
$8.37M
$8.37M paid of $10.71M obligated$8,371,215
Period of performance
Jul 21, 2020 to Dec 31, 2026
Ends in 1 month
Modifications
19
Latest action Sep 8, 2026
Contract type
Definitive contract
PIID 75N93020C00040

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

Dates and value

Award date
Signed on Jul 21, 2020
Current value
$10,706,003Base and exercised options
Potential value (if all options are exercised)
$26,398,541

Obligations by fiscal year of action

  • FY2026: -$22,080 (de-obligation)
  • FY2025: $61,916
  • FY2024: $650,076
  • FY2023: $4,095,421
  • FY2022: $78,993
  • FY2021: $986,612
  • FY2020: $4,855,064

Total across 7 fiscal years: $10,706,003

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 8, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationEAST WINDSOR, NJ
UEIJCL5JKNMYAU5
CAGE code8EWB4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyAURO VACCINES LLC

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Baltimore, Baltimore City, Maryland 21224-6538
Congressional district (place of performance)
MD-07As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
5

Solicitation and notices

Solicitation ID
BAANIAIDNIHAI2016064(as reported)
Solicitation date
Apr 29, 2016

Contract details

Subcontracting plan
Plan not included - no subcontracting possibilitiesA
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 21, 2020Base obligation at award: $4,855,064
Latest action
Sep 8, 2026 — Funding onlyModification P00019; obligation change -$22,080; funding only: changes obligations, not scope
Latest substantive action
Sep 30, 2025 — Supplemental agreement (within scope)Modification P00016; obligation change +$6,800
Latest funding action
Sep 8, 2026 — Funding onlyModification P00019; obligation change -$22,080; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)12
  • Other administrative action3
  • Funding only2
  • Option exercised2
20 actions recorded, Jul 21, 2020 to Sep 8, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$22,080
Latest action: change in base and all options
-$22,080

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
20

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2019/2019-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
Show all 7 accounts
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression